𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised, double blind, placebo controlled crossover trial

✍ Scribed by Heiner Frei; Regula Everts; Klaus Ammon; Franz Kaufmann; Daniel Walther; Shu-Fang Hsu-Schmitz; Marco Collenberg; Katharina Fuhrer; Ralph Hassink; Maja Steinlin; André Thurneysen


Publisher
Springer
Year
2005
Tongue
English
Weight
290 KB
Volume
164
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Double-blind controlled trial of venlafa
✍ Shahrokh Amiri; Sara Farhang; Mohammad Ali Ghoreishizadeh; Ayyoub Malek; Soleima 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

Background Attention deficit/hyperactivity disorder (ADHD) is one of the most common mental disorders beginning in childhood that may continue to adulthood. The purpose of this study was to evaluate the possible therapeutic effect of venlafaxine in adults with ADHD. Methods In a double-blind setting

Amantadine versus methylphenidate in chi
✍ Mohammad-Reza Mohammadi; Mohammad-Reza Kazemi; Ebtehal Zia; Shams-Ali Rezazadeh; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

## Abstract Objective The aim of the present study was to further evaluate, under double blind and controlled conditions, the efficacy of amantadine for attention‐deficit/hyperactivity disorder (ADHD) in children and adolescents as compared to methylphenidate. Methods This was a 6‐week randomized

Efficacy of reboxetine in adults with at
✍ Forough Riahi; Mehdi Tehrani-Doost; Zahra Shahrivar; Javad Alaghband-Rad 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

## Abstract ## Objective The main aim of this study is to evaluate the efficacy of reboxetine, a specific noradrenergic reuptake inhibitor, in adults with attention‐deficit/hyperactivity disorder (ADHD). ## Methods In a double blind placebo‐controlled clinical trial, the efficacy of 8 mg/day of

A randomised double-blind placebo-contro
✍ P. Loiseau; A.W.C. Yuen; B. Duché; T. Ménager; M.C. Arné-Bès 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 874 KB

Efficacy and safety of lamotrigine (LTG) as add-on therapy was assessed in a randomised double-blind placebo-controlled trial of this drug in 23 adult patients with refractory partial seizures. Fifteen patients showed an improvement on LTG treatment, with a greater than 50% decrease in total seizure